a Australian Institute for Bioengineering and Nanotechnology , University of Queensland , Brisbane , Australia.
b ARC Centre of Excellence in Convergent Bio-Nano Science and Technology , Australia.
Expert Opin Drug Deliv. 2018 Jan;15(1):33-45. doi: 10.1080/17425247.2017.1316262. Epub 2017 Apr 13.
Vascular-targeted drug delivery is a promising approach for the treatment of atherosclerosis, due to the vast involvement of endothelium in the initiation and growth of plaque, a characteristic of atherosclerosis. One of the major challenges in carrier design for targeting cardiovascular diseases (CVD) is that carriers must be able to navigate the circulation system and efficiently marginate to the endothelium in order to interact with the target receptors.
This review draws on studies that have focused on the role of particle size, shape, and density (along with flow hemodynamics and hemorheology) on the localization of the particles to activated endothelial cell surfaces and vascular walls under different flow conditions, especially those relevant to atherosclerosis.
Generally, the size, shape, and density of a particle affect its adhesion to vascular walls synergistically, and these three factors should be considered simultaneously when designing an optimal carrier for targeting CVD. Available preliminary data should encourage more studies to be conducted to investigate the use of nano-constructs, characterized by a sub-micrometer size, a non-spherical shape, and a high material density to maximize vascular wall margination and minimize capillary entrapment, as carriers for targeting CVD.
由于血管内皮在斑块的形成和生长中起着重要作用,而斑块正是动脉粥样硬化的特征之一,因此,血管靶向药物输送是治疗动脉粥样硬化的一种很有前途的方法。在针对心血管疾病 (CVD) 的载体设计中,主要面临的挑战之一是载体必须能够在循环系统中导航并有效地迁移到内皮细胞,以便与靶受体相互作用。
本文综述了研究人员集中研究颗粒大小、形状和密度(以及流动血液动力学和血液流变学)在不同流动条件下颗粒定位于激活的内皮细胞表面和血管壁中的作用,尤其是与动脉粥样硬化相关的作用。
一般来说,颗粒的大小、形状和密度协同影响其对血管壁的黏附性,在设计针对 CVD 的最佳载体时,应同时考虑这三个因素。现有初步数据应鼓励开展更多研究,以调查使用亚微米大小、非球形形状和高密度材料的纳米结构作为针对 CVD 的载体,以最大限度地增加血管壁迁移并最小化毛细血管捕获。